Get started
Author

Gérald Tuffin

The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studies
2008 · Birk Poller, Heike Gutmann, et al. · Journal of Neurochemistry · 330
A new drug-release method using the Staudinger ligation
2006 · Michel Azoulay, Gérald Tuffin, et al. · Bioorganic & Medicinal Chemistry Letters · 91
Immunoliposome Targeting to Mesangial Cells
2005 · Gérald Tuffin, Ernst Waelti, et al. · Journal of the American Society of Nephrology · 88
CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2015 · Jingyu Xiang, Michelle A. Hurchla, et al. · Molecular Cancer Therapeutics · 64
Lipopolysaccharide induces intestinal glucocorticoid synthesis in a TNFα‐dependent manner
2010 · Mario Noti, Nadia Corazza, et al. · The FASEB Journal · 49
PDF
Single Application of Low-Dose Mycophenolate Mofetil-OX7-Immunoliposomes Ameliorates Experimental Mesangial Proliferative Glomerulonephritis
2011 · A.J. Suana, G. Tuffin, et al. · Journal of Pharmacology and Experimental Therapeutics · 47
Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti–Vascular Endothelial Growth Factor Therapy–Induced Glioma Dissemination
2017 · Jean-Pierre Gagner, Yasmeen Sarfraz, et al. · American Journal Of Pathology · 40
PDF
POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL
2015 · Edward Allan R. Sison, Daniel Magoon, et al. · Oncotarget · 39
PDF
Pharmacokinetics of Paracetamol in Göttingen Minipigs: In Vivo Studies and Modeling to Elucidate Physiological Determinants of Absorption
2014 · Claudia Suenderhauf, Gerald Tuffin, et al. · Pharmaceutical Research · 37
Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation
2020 · Victoria Poillerat, Thomas Gentinetta, et al. · Frontiers in Immunology · 36
PDF
Podocyte EphB4 signaling helps recovery from glomerular injury
2012 · Monika Wnuk, Ruslan Hlushchuk, et al. · Kidney International · 28
PDF
The Effects of PTK787/ZK222584, an Inhibitor of VEGFR and PDGFRβ Pathways, on Intussusceptive Angiogenesis and Glomerular Recovery from Thy1.1 Nephritis
2011 · Monika Wnuk, Ruslan Hlushchuk, et al. · American Journal Of Pathology · 28
PDF
Drug targeting using OX7-immunoliposomes: Correlation between Thy1.1 antigen expression and tissue distribution in the rat
2008 · Gérald Tuffin, Jörg Huwyler, et al. · Journal of drug targeting · 10
Abstract LB-236: M4-3-ML2, a novel glycoengineered humanized IgG1 antibody, targeting a membrane-proximal epitope of MCSP/CSPG4 exhibits potent ADCC induction in vitro and in vivo anti-tumoral efficacy in disseminated melanoma models
2012 · Ekkehard Mössner, Gerald Tuffin, et al. · Cancer Research · 3
POL5551, a Novel and Potent CXCR4 Antagonist, Enhances Sensitivity to Chemotherapy in an in Vivo Model of High-Risk (HR) Pediatric Acute Lymphoblastic Leukemia (ALL)
2014 · Edward Allan R. Sison, Daniel Magoon, et al. · Blood · 1
A New Drug‐Release Method Using the Staudinger Ligation.
2006 · Michel Azoulay, Gerald Tuffin, et al. · ChemInform · 1
Data from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023 · Jingyu Xiang, Michelle A. Hurchla, et al.
Supplemental Figure 6 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023 · Jingyu Xiang, Michelle A. Hurchla, et al.
Supplemental Figure 5 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023 · Jingyu Xiang, Michelle A. Hurchla, et al.
Supplemental Table 1-3 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023 · Jingyu Xiang, Michelle A. Hurchla, et al.
PDF
Supplemental Figure 4 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023 · Jingyu Xiang, Michelle A. Hurchla, et al.
Supplemental Figure 1-2 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023 · Jingyu Xiang, Michelle A. Hurchla, et al.
Supplemental Figure 7 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023 · Jingyu Xiang, Michelle A. Hurchla, et al.
Supplemental Figure 3 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023 · Jingyu Xiang, Michelle A. Hurchla, et al.
Supplemental Figure 1-2 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023 · Jingyu Xiang, Michelle A. Hurchla, et al.
PDF
Works count: 31
Citation count: 892
H-index: 12
I10-index: 13
Year
Topic
Type